Itamar™ Medical to Report Third Quarter 2019 Financial Results and Host Conference Call on Tuesday, November 26, 2019

Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a company that develops, manufactures and markets non-invasive diagnostic medical devices for sleep apnea and uses a digital healthcare platform to facilitate the continuum of care for effective sleep apnea management with a focus on the cardiology market, announced today that it will report its unaudited financial results for the third quarter of 2019 before the U.S. market opens on Tuesday, November 26, 2019.

CONTACT US
To reach our customer support please send an email to [email protected]
Data Protection
PRIVACY POLICY FOR END USERS
PRIVACY POLICY FOR WEBSITE VISITORS & BUSINESS CONTACTS
Cookie Policy
Terms and Conditions of Sale
Itamar Medical License Agreement
Home Sleep Apnea Test
Itamar Medical - Home Sleep Testing Company Profile
WatchPAT Home Sleep Study Device
Endothelial Dysfunction
Itamar Medical: Medical Device Company & Manufacturer
Diagnosing Sleep Apnea
CONTACT US
© ZOLL Itamar Ltd.
Site by Imaginet
© Itamar Medical Ltd.
Site by Imaginet

When using the marks in our publications and this website, we used the appropriate ™️, ℠, or ®️. The ®️ symbol is used to indicate registrations in the U.S. and the territories listed in https://www.itamar-medical.com/terms-and-conditions/ and this should not mean that such trademarks are necessarily registered in other countries. For example, WatchPAT®️ is a trademark of Itamar Medical Ltd a subsidiary of ZOLL Medical Corporation, in the United States and/or other countries. All other trademarks are the property of their respective owners., registered in the U.S. and the applicable territories listed inhttps://www.itamar-medical.com/terms-and-conditions/ only.

Menu